PIRODOG, liofilizat i otapalo za suspenziju za injekciju, za pse
PIRODOG, liofilizat i otapalo za suspenziju za injekciju, za pse
Not authorised
- Babesia canis, soluble parasite antigen, Inactivated
Product identification
Medicine name:
PIRODOG, liofilizat i otapalo za suspenziju za injekciju, za pse
Active substance:
- Babesia canis, soluble parasite antigen, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Babesia canis, soluble parasite antigen, Inactivated2.20/log10 immunofluorescence unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AO
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/18-01/12
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 18/02/2022
How useful was this page?:
